C57BL/6JCya-Taar1em1flox/Cya
Common Name
Taar1-flox
Product ID
S-CKO-00917
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-111174-Taar1-B6J-VA
Status
When using this mouse strain in a publication, please cite “Taar1-flox Mouse (Catalog S-CKO-00917) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Taar1-flox
Strain ID
CKOCMP-111174-Taar1-B6J-VA
Gene Name
Product ID
S-CKO-00917
Gene Alias
Tar1, Trar1, taR-1
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 10
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000051532
NCBI RefSeq
NM_053205
Target Region
Exon 1
Size of Effective Region
~1.7 kb
Overview of Gene Research
Trace amine-associated receptor 1 (TAAR1) senses endogenous amine-containing metabolites (EAMs) and is involved in mediating diverse psychological functions [1]. It modulates monoamine transmission, especially dopamine, and is widely distributed in the monoaminergic system in the mammalian brain, including areas like the ventral tegmental area and substantia nigra [3]. TAAR1 is considered a promising target for treating psychiatric disorders such as schizophrenia, substance use disorders, and sleep, depression, and anxiety-related disorders [3].
Studies in Taar1 knockout (TAAR1-KO) rodents show that TAAR1 agonism inhibits midbrain dopaminergic and serotonergic activity, and enhances prefrontal glutamatergic function [2]. In preclinical models of psychostimulant addiction, activation of TAAR1 attenuated while knockout of TAAR1 potentiated psychostimulant abuse-related behaviors [5]. These suggest that TAAR1 negatively modulates monoamine-related activities and behaviors [4].
In conclusion, TAAR1 plays a crucial role in modulating monoamine transmission and is involved in various psychiatric disorders. The use of TAAR1-KO mouse models has revealed its role in regulating midbrain neurotransmitter activities and psychostimulant-related behaviors, providing valuable insights for developing treatments for schizophrenia and substance use disorders.
References:
1. Shang, Pan, Rong, Naikang, Jiang, Jing-Jing, Yang, Fan, Sun, Jin-Peng. 2023. Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. In Cell, 186, 5347-5362.e24. doi:10.1016/j.cell.2023.10.014. https://pubmed.ncbi.nlm.nih.gov/37963465/
2. Halff, Els F, Rutigliano, Grazia, Garcia-Hidalgo, Anna, Howes, Oliver D. 2022. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. In Trends in neurosciences, 46, 60-74. doi:10.1016/j.tins.2022.10.010. https://pubmed.ncbi.nlm.nih.gov/36369028/
3. Liu, Jianfeng, Wu, Ruyan, Li, Jun-Xu. 2023. TAAR1 as an emerging target for the treatment of psychiatric disorders. In Pharmacology & therapeutics, 253, 108580. doi:10.1016/j.pharmthera.2023.108580. https://pubmed.ncbi.nlm.nih.gov/38142862/
4. Liu, Jian-Feng, Li, Jun-Xu. 2018. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg. In Frontiers in pharmacology, 9, 279. doi:10.3389/fphar.2018.00279. https://pubmed.ncbi.nlm.nih.gov/29636691/
5. Liu, Jianfeng, Wu, Ruyan, Li, Jun-Xu. 2020. TAAR1 and Psychostimulant Addiction. In Cellular and molecular neurobiology, 40, 229-238. doi:10.1007/s10571-020-00792-8. https://pubmed.ncbi.nlm.nih.gov/31974906/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
